Results 171 to 180 of about 27,114 (287)

[Change from Sjögren syndrome to Sjögren disease]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Liu Y, Shi G.
europepmc   +1 more source

Parkinson's Disease and Salivary Issues: A Survey

open access: yesGerodontology, Volume 43, Issue 2, Page 234-244, June 2026.
ABSTRACT Background Salivary dysfunction, including xerostomia and drooling, is common in Parkinson's disease and further impairs oral health and quality of life, which are already compromised in this population. Their effective management demands deeper insight into the complexity of salivary dysfunction.
Beau D. M. van Dijk   +3 more
wiley   +1 more source

Continued Involvement: A Scoping Review on Family Members' Needs and Experiences Collaborating With Support Staff for Relatives With Intellectual Disabilities Living Outside the Family Home

open access: yesJournal of Intellectual Disability Research, Volume 70, Issue 6, Page 561-578, June 2026.
ABSTRACT Background Family members' involvement in the care for their relative often continues after their relative has moved out of the family home. However, little is known about the needs of family members when collaborating specifically with support staff caring for their relative.
Frances R. Vereijken   +3 more
wiley   +1 more source

Repeated Unstimulated Whole Saliva Collection: A Reliable Approach to Improve Diagnostic Accuracy

open access: yesJournal of Oral Rehabilitation, Volume 53, Issue 6, Page 1169-1176, June 2026.
Sixty‐two healthy participants provided unstimulated whole saliva by passive drooling for 5 min, three times daily for three consecutive days (nine samples). Single measurements showed high intra‐subject variability and limited reproducibility. Averaging repeated, standardised collections improved reliability and may enhance diagnostic accuracy ...
Gennaro Musella   +7 more
wiley   +1 more source

Detection of Diagnostic Antibodies in Immune‐Mediated Diseases: A Focus on Antigens and Technologies

open access: yesChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Silvia Bracci   +5 more
wiley   +1 more source

Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness Registry

open access: yesACR Open Rheumatology, Volume 8, Issue 5, May 2026.
Objective Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) such as semaglutide (SEM) and tirzepatide (TZP) were initially approved for type 2 diabetes management but are increasingly used for weight loss. Limited data exist on real‐world use among patients with rheumatic and musculoskeletal diseases (RMDs).
Nicholas P. McCormick   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy